Noxopharm to transform cancer treatment space

Drug Discovery |  News | 0 Comment | 29 Jan, 2020

Headquartered in Australia, Noxopharm Limited is a clinical stage drug development company that has been in the limelight for its potential industry disruptive and revolutionary cancer...Read more

PerkinElmer unveils Advanced Drug Discovery and Disease Research Solutions

Drug Discovery |  News | 0 Comment | 28 Jan, 2020

PerkinElmer, Inc., a global leader committed to innovating for a healthier world,  introduced new workstations and a high content screening system at SLAS2020 International Confer...Read more

CEPI selects Inovio to develop vaccine against coronavirus

Drug Discovery |  News | 0 Comment | 28 Jan, 2020

US based Inovio Pharmaceuticals, has announced the Coalition for Epidemic Preparedness Innovations (CEPI) has awarded Inovio a grant of up to $9 million to develop a vaccine against the rec...Read more

Darolutamide gets marketing authorization in Japan

Drug Discovery |  News | 0 Comment | 24 Jan, 2020

The Japanese Ministry of Health, Labor and Welfare (MHLW) has granted marketing authorization for darolutamide, under the brand name Nubeqa®, for the treatment of men with non-metastati...Read more

RegeneRx Biopharma receives patent in Korea

Drug Discovery |  News | 0 Comment | 23 Jan, 2020

US based RegeneRx Biopharmaceuticals, a clinical-stage drug development company focused on tissue protection, repair and regeneration, reported that the Korean Intellectual Property Of...Read more

Hitachi Chemical inks pact with Ori Biotech

Drug Discovery |  News | 0 Comment | 23 Jan, 2020

Hitachi Chemical Advanced Therapeutics Solutions, LLC,  a US subsidiary of Japanese firm Hitachi Chemical Co., Ltd. that engages in contract manufacturing and manufacturing development...Read more

PhoreMost, Otsuka collaborate for multi drug discovery projects

Drug Discovery |  News | 0 Comment | 22 Jan, 2020

PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, has entered into a multi-project collaboration with Japan's Otsuka...Read more

ViiV Healthcare wins Japanese approval for Dovato to treat HIV-1

Drug Discovery |  News | 0 Comment | 20 Jan, 2020

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, announced that it has obtained approval of Dovato (dolutegra...Read more

InterVenn Biosciences advances glycoproteomics for complex disease therapies

Drug Discovery |  News | 0 Comment | 17 Jan, 2020

US based InterVenn Biosciences has announced multiple achievements in its development of AI-enabled glycoproteomics, as it looks to solving difficult challenges in various disease areas of ...Read more

Charles River inks scientific collaboration with Takeda

Drug Discovery |  News | 0 Comment | 16 Jan, 2020

US based company Charles River has announced a multi-year drug discovery collaboration with Japanese firm Takeda Pharmaceutical Company Limited. Together, Charles River and Takeda will laun...Read more

Hitachi starts commercial manufacturing of Zynteglo

Drug Discovery |  News | 0 Comment | 15 Jan, 2020

apceth Biopharma GmbH, a subsidiary of Japan headquartered Hitachi Chemical Co., Ltd. and a leading company for the manufacturing of cell and gene therapeutics, starts the commercial manufa...Read more

FDA approves sNDA for Astellas’s antifungal drug

Drug Discovery |  News | 0 Comment | 13 Jan, 2020

Japan based Astellas Pharma Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for MYCAMINE® (micafungin ...Read more

China approves AstraZeneca’s Lokelma to treat hyperkalaemia

Drug Discovery |  News | 0 Comment | 07 Jan, 2020

AstraZeneca’s Lokelma (sodium zirconium cyclosilicate) has been approved in China for the treatment of adult patients with hyperkalaemia (elevated levels of potassium in the...Read more

China grants priority review to Luye Pharma's schizophrenia drug

Drug Discovery |  News | 0 Comment | 02 Jan, 2020

Luye Pharma Group has announced that the New Drug Application (NDA) for Risperidone Extended-Release Microspheres for Injection (LY03004), an innovative formulation independently developed ...Read more

AstraZeneca’s triple-combination therapy gets approval in China for COPD

Drug Discovery |  News | 0 Comment | 01 Jan, 2020

AstraZeneca has announced that budesonide/glycopyrronium/formoterol fumarate has been approved in China for the maintenance treatment of chronic obstructive pulmonary disease (COPD). This ...Read more

Luye Pharma seeks USFDA approval for antidepressant drug

Drug Discovery |  News | 0 Comment | 30 Dec, 2019

China based Luye Pharma Group has announced submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for LY03005, a new chemical drug for the treatment of m...Read more

USFDA approves Daiichi Sankyo and AstraZeneca’s breast cancer drug

Drug Discovery |  News | 0 Comment | 26 Dec, 2019

Daiichi Sankyo and AstraZeneca have announced that the U.S. Food and Drug Administration (FDA) has approved ENHERTU® (fam-trastuzumab deruxtecan-nxki), a HER2 directed antibody drug con...Read more

Allergan gets FDA nod for acute migraine treatment

Drug Discovery |  News | 0 Comment | 24 Dec, 2019

The U.S. Food and Drug Administration has approved Ubrelvy (ubrogepant) tablets for the acute (immediate) treatment of migraine with or without aura (a sensory phenomenon or visual disturba...Read more